drugset / Trial / NCT02958046

The Efficacy of Lansoprazole and Domperidone Combination on Intragastric and Intraesophageal Acidity

NCT02958046

Phase 4 Completed 12 enrolled Neutec Ar-Ge San ve Tic A.Ş
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to investigate the efficacy of lansoprazole combination with domperidone on intragastric acidity and intraesophageal acidity, GERD symptoms, impedance kinetics, gastric emptying in patients with gastroesophageal reflux disease (GERD).

Timeline

Start
2014-01
Primary completion
2015-05
Completion
2015-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Domperidone Unknown 30 mg Oral
Subject Lansoprazole Other / unclassified 30 mg Oral